GSA CAPITAL PARTNERS LLP - ACTINIUM PHARMACEUTICALS INC ownership

ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 40 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 3.29 and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of ACTINIUM PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$341,000
-43.5%
56,673
-16.9%
0.04%
-30.6%
Q3 2021$604,000
+61.9%
68,205
+44.8%
0.06%
+47.6%
Q2 2021$373,000
+25.6%
47,097
+20.7%
0.04%
-14.3%
Q1 2021$297,000
+121.6%
39,006
+182.2%
0.05%
+122.7%
Q3 2020$134,00013,8230.02%
Other shareholders
ACTINIUM PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Corton Capital Inc. 13,966$103,0000.13%
Delphia (USA) Inc. 14,226$105,0000.12%
Sentinus, LLC 22,500$166,0000.10%
Intrepid Financial Planning Group LLC 20,000$148,0000.08%
PERRITT CAPITAL MANAGEMENT INC 12,000$89,0000.06%
J. Goldman & Co LP 148,738$1,098,0000.05%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 88,966$657,0000.02%
EMFO, LLC 1,666$12,0000.01%
Virtu Financial LLC 12,590$93,0000.01%
Jump Financial, LLC 23,400$173,0000.01%
View complete list of ACTINIUM PHARMACEUTICALS INC shareholders